These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37277075)

  • 41. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery.
    Özbaş B; Keskin O; Hecker H; Karahan I; Özbaş C; Kalkan Ç; Kartal A; Önder FO; Öncü BK; Gençdal G; Akyildiz M; Günşar F; Idilman R; Weissenborn K; Özütemiz Ö; Yurdaydin C
    Hepatol Int; 2021 Dec; 15(6):1442-1455. PubMed ID: 34085147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study.
    Miwa T; Hanai T; Hirata S; Nishimura K; Sahashi Y; Unome S; Imai K; Shirakami Y; Suetsugu A; Takai K; Shimizu M
    Clin Nutr ESPEN; 2024 Oct; 63():267-273. PubMed ID: 38972037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
    Montagnese S; Biancardi A; Schiff S; Carraro P; Carlà V; Mannaioni G; Moroni F; Tono N; Angeli P; Gatta A; Amodio P
    Hepatology; 2011 Feb; 53(2):558-66. PubMed ID: 21274876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study.
    Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Gabriel M; Ehrenbauer AF; Bloom PP; Ripoll C; Sultanik P; Galle PR; Labenz J; Thabut D; Zipprich A; Lok AS; Weissenborn K; Marquardt JU; Lauridsen MM; Nardelli S; Montagnese S; Labenz C
    Am J Gastroenterol; 2023 Dec; 118(12):2191-2200. PubMed ID: 36940426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability.
    Formentin C; De Rui M; Zoncapè M; Ceccato S; Zarantonello L; Senzolo M; Burra P; Angeli P; Amodio P; Montagnese S
    J Hepatol; 2019 Apr; 70(4):648-657. PubMed ID: 30633946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.
    Tong H; Gan C; Wei B; Wang ZD; Li XD; Qian SJ; Huan H; Zhang LH; Yang Z; Chen YL; Gu YH; Chen LX; Yang YH; Wu H; Tang CW
    J Dig Dis; 2021 Jan; 22(1):31-40. PubMed ID: 33128287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy.
    Metwally MA; Biomy HA; Omar MZ; Sakr AI
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1030-1034. PubMed ID: 31274595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.
    Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS
    Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Riggio O; Amodio P; Farcomeni A; Merli M; Nardelli S; Pasquale C; Pentassuglio I; Gioia S; Onori E; Piazza N; De Rui M; Schiff S; Montagnese S
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1346-52. PubMed ID: 25572976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.
    Luo M; Li L; Yang EN; Dai CY; Liang SR; Cao WK
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):384-90. PubMed ID: 23084463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study.
    Fagan A; Gavis EA; Gallagher ML; Mousel T; Davis B; Puri P; Sterling RK; Luketic VA; Lee H; Matherly SC; Sanyal AJ; Stravitz RT; Patel V; Siddiqui MS; Asgharpour A; Fuchs M; Thacker L; Bajaj JS
    J Hepatol; 2023 Feb; 78(2):312-321. PubMed ID: 36152764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2010; 16(3):181-7. PubMed ID: 20616413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients.
    Liao Y; Zhang L; Wang JT; Yue ZD; Fan ZH; Wu YF; Zhang Y; Dong CB; Wang XQ; Cui T; Meng MM; Bao L; Chen SB; Liu FQ; Wang L
    Sci Rep; 2023 Sep; 13(1):15244. PubMed ID: 37709823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
    Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant topological organization of the functional brain network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Chen HJ; Chen QF; Yang ZT; Shi HB
    Brain Imaging Behav; 2019 Jun; 13(3):771-780. PubMed ID: 29846883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PHES scores have limited impact on the risk of overt HE in patients with minimal HE.
    Gairing SJ; Mangini C; Zarantonello L; Jonasson E; Danneberg S; Sultanik P; Galle PR; Gioia S; Labenz J; Lok AS; Marquardt JU; Lauridsen MM; Bloom PP; Thabut D; Nardelli S; Montagnese S; Labenz C
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38701395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy.
    Miwa T; Hanai T; Toshihide M; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
    Hepatol Res; 2021 Jun; 51(6):662-673. PubMed ID: 33242359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.
    Senzolo M; Zarantonello L; Formentin C; Orlando C; Beltrame R; Vuerich A; Angeli P; Burra P; Montagnese S
    Metab Brain Dis; 2019 Dec; 34(6):1803-1812. PubMed ID: 31506797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.